pharmaceuticals-and-healthcare

Global Drugs for Vulvovaginal Candidiasis Market Professional Survey Report 2018


Published On : Jul 2018

Category : Pharmaceutical

No. of Pages : 108 pages

  • $3500
  • $7000

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global Drugs for Vulvovaginal Candidiasis market status and forecast, categorizes the global Drugs for Vulvovaginal Candidiasis market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for at least 72 hours after the ingestion of a single 150-mg tablet.

Some women with recurrent candidal infections opt for treatment with over-the-counter (OTC) medications, which generally are highly effective for candidiasis. Preparations for intravaginal administration of butoconazole, clotrimazole, miconazole, and tioconazole are available OTC.
The classification of Drugs for Vulvovaginal Candidiasis includes Cream, Pessary and other. The proportion of Cream in 2017 is about 47.2%, and the proportion of Pessary in 2017 is about 34.1%.
The drugs for Vulvovaginal Candidiasis are Miconazole, Clotrimazole, Fluconazole, Econazole and Other, market share of Fluconazole is about 24.5% in 2017.
Drugs for Vulvovaginal Candidiasis is application in Hospital & Clinic and Pharmacy. The most of Drugs for Vulvovaginal Candidiasis is used in Pharmacy, and the market share in 2016 is about 59%.
The global Drugs for Vulvovaginal Candidiasis market is valued at 770 million US$ in 2017 and will reach 860 million US$ by the end of 2025, growing at a CAGR of 1.5% during 2018-2025.

The major manufacturers covered in this report
Bayer
Perrigo
J & J
Pfizer
Bristol-Myers Squibb
Effik
Teva
Sanofi
Cisen Pharmaceutical
Kingyork Group

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Formulation Types
Cream
Pessary
Other
By Drugs Types
Miconazole
Clotrimazole
Fluconazole
Econazole
Other

By Application, the market can be split into
Hospital & Clinic
Pharmacy

The study objectives of this report are:
To analyze and study the global Drugs for Vulvovaginal Candidiasis capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Drugs for Vulvovaginal Candidiasis manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Drugs for Vulvovaginal Candidiasis are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Drugs for Vulvovaginal Candidiasis Manufacturers
Drugs for Vulvovaginal Candidiasis Distributors/Traders/Wholesalers
Drugs for Vulvovaginal Candidiasis Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Drugs for Vulvovaginal Candidiasis market, by end-use.
Detailed analysis and profiles of additional market players.

In the recent times, the global market for Global drugs for vulvovaginal candidiasis market professional survey report 2018 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global drugs for vulvovaginal candidiasis market professional survey report 2018 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global drugs for vulvovaginal candidiasis market professional survey report 2018 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global drugs for vulvovaginal candidiasis market professional survey report 2018 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global drugs for vulvovaginal candidiasis market professional survey report 2018 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global drugs for vulvovaginal candidiasis market professional survey report 2018, including the definition, classification, and industry chain structure of Global drugs for vulvovaginal candidiasis market professional survey report 2018, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global drugs for vulvovaginal candidiasis market professional survey report 2018.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global drugs for vulvovaginal candidiasis market professional survey report 2018 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global drugs for vulvovaginal candidiasis market professional survey report 2018, implemented in each of the geographical segments. The predominant applications of the Global drugs for vulvovaginal candidiasis market professional survey report 2018 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global drugs for vulvovaginal candidiasis market professional survey report 2018 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global drugs for vulvovaginal candidiasis market professional survey report 2018 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures
Figure Picture of Drugs for Vulvovaginal Candidiasis
Table Product Specifications of Drugs for Vulvovaginal Candidiasis
Table Classification of Drugs for Vulvovaginal Candidiasis
Figure Global Production Market Share of Drugs for Vulvovaginal Candidiasis by Type in 2017
Figure Cream Picture
Table Major Manufacturers of Cream
Figure Pessary Picture
Table Major Manufacturers of Pessary
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Drugs for Vulvovaginal Candidiasis
Figure Global Consumption Volume Market Share of Drugs for Vulvovaginal Candidiasis by Application in 2017
Figure Hospital & Clinic Examples
Table Major Consumers in Hospital & Clinic
Figure Pharmacy Examples
Table Major Consumers in Pharmacy
Figure Market Share of Drugs for Vulvovaginal Candidiasis by Regions
Figure North America Drugs for Vulvovaginal Candidiasis Market Size (Million USD) (2013-2025)
Figure Europe Drugs for Vulvovaginal Candidiasis Market Size (Million USD) (2013-2025)
Figure China Drugs for Vulvovaginal Candidiasis Market Size (Million USD) (2013-2025)
Figure Japan Drugs for Vulvovaginal Candidiasis Market Size (Million USD) (2013-2025)
Figure Southeast Asia Drugs for Vulvovaginal Candidiasis Market Size (Million USD) (2013-2025)
Figure India Drugs for Vulvovaginal Candidiasis Market Size (Million USD) (2013-2025)
Table Drugs for Vulvovaginal Candidiasis Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Drugs for Vulvovaginal Candidiasis in 2017
Figure Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
Figure Industry Chain Structure of Drugs for Vulvovaginal Candidiasis
Table Capacity and Commercial Production Date of Global Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Drugs for Vulvovaginal Candidiasis 2013-2018E
Figure Global 2013-2018E Drugs for Vulvovaginal Candidiasis Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Drugs for Vulvovaginal Candidiasis Market Size (Value) and Growth Rate
Table 2013-2018E Global Drugs for Vulvovaginal Candidiasis Capacity and Growth Rate
Table 2017 Global Drugs for Vulvovaginal Candidiasis Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Drugs for Vulvovaginal Candidiasis Sales (K Units) and Growth Rate
Table 2017 Global Drugs for Vulvovaginal Candidiasis Sales (K Units) List (Company Segment)
Table 2013-2018E Global Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit)
Table 2017 Global Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Drugs for Vulvovaginal Candidiasis 2013-2018E
Figure North America 2013-2018E Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit)
Figure North America 2017 Drugs for Vulvovaginal Candidiasis Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Drugs for Vulvovaginal Candidiasis 2013-2018E
Figure Europe 2013-2018E Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit)
Figure Europe 2017 Drugs for Vulvovaginal Candidiasis Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Drugs for Vulvovaginal Candidiasis 2013-2018E
Figure China 2013-2018E Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit)
Figure China 2017 Drugs for Vulvovaginal Candidiasis Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Drugs for Vulvovaginal Candidiasis 2013-2018E
Figure Japan 2013-2018E Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit)
Figure Japan 2017 Drugs for Vulvovaginal Candidiasis Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Drugs for Vulvovaginal Candidiasis 2013-2018E
Figure Southeast Asia 2013-2018E Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit)
Figure Southeast Asia 2017 Drugs for Vulvovaginal Candidiasis Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Drugs for Vulvovaginal Candidiasis 2013-2018E
Figure India 2013-2018E Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit)
Figure India 2017 Drugs for Vulvovaginal Candidiasis Sales Market Share
Table Global 2013-2018E Drugs for Vulvovaginal Candidiasis Sales (K Units) by Type
Table Different Types Drugs for Vulvovaginal Candidiasis Product Interview Price
Table Global 2013-2018E Drugs for Vulvovaginal Candidiasis Sales (K Units) by Application
Table Different Application Drugs for Vulvovaginal Candidiasis Product Interview Price
Table Bayer Information List
Table Product Overview
Table 2017 Bayer Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bayer Drugs for Vulvovaginal Candidiasis Business Region Distribution
Table Perrigo Information List
Table Product Overview
Table 2017 Perrigo Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Perrigo Drugs for Vulvovaginal Candidiasis Business Region Distribution
Table J & J Information List
Table Product Overview
Table 2017 J & J Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 J & J Drugs for Vulvovaginal Candidiasis Business Region Distribution
Table Pfizer Information List
Table Product Overview
Table 2017 Pfizer Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Pfizer Drugs for Vulvovaginal Candidiasis Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Product Overview
Table 2017 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Business Region Distribution
Table Effik Information List
Table Product Overview
Table 2017 Effik Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Effik Drugs for Vulvovaginal Candidiasis Business Region Distribution
Table Teva Information List
Table Product Overview
Table 2017 Teva Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Teva Drugs for Vulvovaginal Candidiasis Business Region Distribution
Table Sanofi Information List
Table Product Overview
Table 2017 Sanofi Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Sanofi Drugs for Vulvovaginal Candidiasis Business Region Distribution
Table Cisen Pharmaceutical Information List
Table Product Overview
Table 2017 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Business Region Distribution
Table Kingyork Group Information List
Table Product Overview
Table 2017 Kingyork Group Drugs for Vulvovaginal Candidiasis Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Kingyork Group Drugs for Vulvovaginal Candidiasis Business Region Distribution
Figure Global 2018-2025 Drugs for Vulvovaginal Candidiasis Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Drugs for Vulvovaginal Candidiasis Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Drugs for Vulvovaginal Candidiasis Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Drugs for Vulvovaginal Candidiasis Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Drugs for Vulvovaginal Candidiasis Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Drugs for Vulvovaginal Candidiasis Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Drugs for Vulvovaginal Candidiasis Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Drugs for Vulvovaginal Candidiasis Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Drugs for Vulvovaginal Candidiasis Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Drugs for Vulvovaginal Candidiasis by Type 2018-2025
Table Global Consumption Volume (K Units) of Drugs for Vulvovaginal Candidiasis by Application 2018-2025
Table Traders or Distributors with Contact Information of Drugs for Vulvovaginal Candidiasis by Region

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top